Jay Shepard
CIK 1587788 · President and CEO · last filed 2026-07-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$902.6K
Companies
7
Total Filings
60
Lifetime Open-Market Net
-$1.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESPR | Director | 0 | $3.18 | $0 | $0 | 10 | 2026-07-13 |
| IRWD | Director | 235,036 | $3.80 | $893.1K | $0 | 7 | 2026-06-17 |
| INO | Director | 9,209 | $1.03 | $9.5K | $0 | 12 | 2026-05-21 |
| Aravive, Inc. (ARAV) Delisted | President and CEO | 61,201 | $0.04 | $2.5K | -$99.3K | 9 | 2020-04-09 |
| Aravive, Inc. (VSAR) Delisted | President and CEO | 98,844 | — | — | -$1.36M | 13 | 2018-05-23 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | — | $0.55 | — | $0 | 4 | 2017-01-19 |
| DURECT CORP (DRRX) Delisted | Director | — | $1.91 | — | $0 | 5 | 2016-06-23 |
Recent Filings · Page 4 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-10-08 | Aravive, Inc. (ARAV) Delisted | Sell (S) | −4,004 | -$27.3K | EDGAR |
| 2019-05-31 | ESPR | Grant (A) | +4,967 | $0 | EDGAR |
| 2019-05-13 | Aravive, Inc. (ARAV) Delisted | Sell (S) | −1,192 | -$7.3K | EDGAR |
| 2019-03-04 | Aravive, Inc. (ARAV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-05 | Aravive, Inc. (ARAV) Delisted | Sell (S) | −2,163 | -$9.0K | EDGAR |
| 2018-12-26 | Aravive, Inc. (ARAV) Delisted | Sell (S) | −3,484 | -$11.2K | EDGAR |
| 2018-12-19 | Aravive, Inc. (ARAV) Delisted | Sell (S) | −11,247 | -$44.6K | EDGAR |
| 2018-05-29 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2018-05-23 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −9,232 | -$13.8K | EDGAR |
| 2018-02-12 | Aravive, Inc. (VSAR) Delisted | Sell (S) | −14,446 | -$26.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.